We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+15.21%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$436B
AUM Growth
+$83.7B
Cap. Flow
+$35.4B
Cap. Flow %
8.11%
Top 10 Hldgs %
42.78%
Holding
5,681
New
461
Increased
2,914
Reduced
1,346
Closed
463

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.6B
2
AVGO icon
Broadcom
AVGO
+$1.11B
3
QQQ icon
Invesco QQQ Trust
QQQ
+$882M
4
JPM icon
JPMorgan Chase
JPM
+$628M
5
TSLA icon
Tesla
TSLA
+$594M

Sector Composition

Rank Sector Weight
1 Technology 19.83%
2 Financials 7.37%
3 Consumer Discretionary 6.6%
4 Communication Services 5.05%
5 Healthcare 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MURA
5001
DELISTED
Mural Oncology
MURA
$10 ﹤0.01%
4
XMAX
5002
XMAX Inc
XMAX
$581M
$10 ﹤0.01%
7
RENT
5003
Rent the Runway
RENT
$122M
$10 ﹤0.01%
2
STHO icon
5004
Star Holdings Shares of Beneficial Interest
STHO
$115M
$8 ﹤0.01%
1
-13,027
-100% -$90K
VRCA icon
5005
Verrica Pharmaceuticals
VRCA
$91.7M
$8 ﹤0.01%
2
-4,436
-100% -$23.9K
CPIX icon
5006
Cumberland Pharmaceuticals
CPIX
$120M
$7 ﹤0.01%
+2
New +$9
MNTS icon
5007
Momentus
MNTS
$88.7M
0
JSPR icon
5008
Jasper Therapeutics
JSPR
$26.3M
$6 ﹤0.01%
1
-17,959
-100% -$88.4K
ONL
5009
Orion Office REIT
ONL
$156M
$6 ﹤0.01%
3
-56,528
-100% -$108K
SERA icon
5010
Sera Prognostics
SERA
$78.3M
$6 ﹤0.01%
2
-31,078
-100% -$76.9K
UHG
5011
DELISTED
United Homes Group
UHG
$6 ﹤0.01%
2
-9,389
-100% -$24.4K
AGEN
5012
Agenus
AGEN
$285M
$5 ﹤0.01%
1
-26,301
-100% -$91.1K
CTMX icon
5013
CytomX Therapeutics
CTMX
$741M
$5 ﹤0.01%
2
FTCI icon
5014
FTC Solar
FTCI
$47.1M
$5 ﹤0.01%
1
KZR
5015
DELISTED
Kezar Life Sciences
KZR
$5 ﹤0.01%
1
VATE icon
5016
INNOVATE Corp
VATE
$96M
$5 ﹤0.01%
1
BLUE
5017
DELISTED
bluebird bio
BLUE
$4 ﹤0.01%
1
-9,812
-100% -$43.9K
FLL icon
5018
Full House Resorts
FLL
$92.3M
$4 ﹤0.01%
1
-34,060
-100% -$114K
OMEX icon
5019
Odyssey Marine Exploration
OMEX
$50.8M
$4 ﹤0.01%
3
-54
-95% -$49
MGX icon
5020
Metagenomi Therapeutics
MGX
$46.3M
$4 ﹤0.01%
3
-28,845
-100% -$45.2K
ASRT
5021
DELISTED
Assertio
ASRT
-291
Closed -$2.8K
CBUS icon
5022
Cibus
CBUS
$150M
$3 ﹤0.01%
2
-18,393
-100% -$37.4K
MBOT icon
5023
Microbot Medical
MBOT
$130M
$3 ﹤0.01%
1
-5
-83% -$12
SWVLW icon
5024
Swvl Holdings Corp Warrant
SWVLW
$3 ﹤0.01%
238
XBIT icon
5025
XBiotech
XBIT
$69.8M
$3 ﹤0.01%
1
-20,107
-100% -$58.5K

Similar funds

Barclays's Q2 2025 Portfolio in Review

As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.

  • Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
  • Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
  • Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
  • Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
  • Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
  • Barclays opened 461 new positions and closed 463 in Q2 2025.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $436B.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.